Takeda Secures Exclusive Rights to ImmunoGen’s Elahere in Japan Through New Agreement
Japanese pharmaceutical company Takeda (TYO: 4502) has entered into an exclusive collaboration and license agreement...
Deals
Ronovo Surgical Secures Pre-Series B+ Funding to Advance Modular Surgical Robots
Shanghai-based minimally invasive surgical robot developer, Ronovo Surgical, has reportedly raised close to RMB 200...
Kangpu Biopharmaceuticals Secures Series B Funding to Advance Molecular Glue Therapies
Shanghai-based Kangpu Biopharmaceuticals, Ltd has reportedly raised close to RMB 100 million (USD 13.8 million)...
Epigenic Therapeutics Secures $32 Million in Series A Funding for Gene Modulation Therapy
Epigenic Therapeutics, a Shanghai-based biotech company specializing in gene modulation therapy through epigenome regulation, has...
Biocytogen Pharmaceuticals’ Eucure Biopharma Expands Partnership with Syncromune on Immunotherapies
China-based Biocytogen Pharmaceuticals (Beijing) Co., Ltd’s (HKG: 2315) wholly owned subsidiary, Eucure Biopharma, has announced...
Mabwell Bioscience Secures Deal with UNILAB for Biosimilar Humira in the Philippines
China-based Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) has announced a licensing and supply agreement...
HanchorBio and Henlius Pharmaceutical Enter Strategic Collaboration for Immunotherapies
Taiwan-based HanchorBio has entered into a strategic cooperation framework agreement with Shanghai-headquartered Shanghai Henlius Biotech,...
Sandoz Expands Anti-Infective Portfolio with Acquisition of Astellas Pharma’s Antifungal Mycamine
Switzerland-based Novartis (NYSE: NVS) subsidiary Sandoz has bolstered its global anti-infectives portfolio with the acquisition...
BMS Partners with Cellares for Automated CAR-T Cell Therapy Production
Pharmaceutical giant Bristol-Myers Squibb (BMS; NYSE: BMY) has entered into an agreement with cell therapy...
Takeda and BridGene Biosciences Achieve Milestone in Neurodegenerative Disorder Target Identification
A 2021 collaboration between Japan’s Takeda (TYO: 4502) and US-based BridGene Biosciences has successfully reached...
GenFleet Therapeutics and Verastem Oncology Ink Licensing Deal for RAS Pathway Cancer Therapies
China-based GenFleet Therapeutics has entered into an exclusive licensing and early development agreement with US...
Henlius Biotech Expands Licensing Agreement with KGbio for PD-1 Inhibitor
Shanghai Henlius Biotech Co., Ltd (HKG: 2696) has announced an update to the licensing agreement...
Chinese Pharma Consortium Eyes Poland’s Neuca in Strategic European Market Acquisition
A consortium of China-based pharmaceutical companies, potentially including the state-owned giant Sinopharm (HKG: 1099), is...
CanSino Biologics to Expand Southeast Asian Presence with Solution Group Berhad Stake
China-based CanSino Biologics (SHA: 688185, HKG: 6185) is poised to acquire an undisclosed amount of...
CSH MEDI Secures Series A+ Funding to Advance Biomagnetic Equipment Technology
CSH MEDI, a Shanghai-based biomagnetic equipment manufacturer, has reportedly raised close to RMB 100 million...
Neurodawn Pharmaceutical and China Medical System Holdings Ink Licensing Deal for Y-3
Nanjing-based Neurodawn Pharmaceutical Co., Ltd has entered into a significant licensing deal with China Medical...
Cordavis Launches First Biosimilar: Novartis’ Hyrimoz to Compete with Humira
Swiss pharmaceutical giant Novartis (NYSE: NVS) unit Sandoz’s biosimilar product, Hyrimoz (adalimumab), which references AbbVie’s...
ImmuneOnco Biopharmaceuticals Launches IPO to Raise HKD 319 Million on Hong Kong Stock Exchange
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd (HKG: 1541) is poised to raise HKD 319 million (USD...
Labway Clinical Laboratory Partners with 10x Genomics for Precision Medicine Advancements
Shanghai Labway Clinical Laboratory Co., Ltd., a leading provider of medical laboratory and pathological diagnostic...